Sign in Subscribe
Pharmaceutical industry

Global Peptide Therapeutics Market to Reach USD 51,360.30 Million by 2026 with a CAGR of 9.66%

Strategic Insights

— 2 min read

The global peptide therapeutics market is expected to experience significant growth over the forecast period, driven by the increasing prevalence of cancer and metabolic disorders worldwide. The market was valued at approximately USD 28,510.60 million in 2020 and is expected to reach USD 51,360.30 million by 2026, with a Compound Annual Growth Rate (CAGR) of 9.66%. The North America region is expected to dominate the market, with the United States holding the largest market share due to factors such as a growing number of research programs in the medical industry and a high incidence of diseases.

Key Takeaways:

  • Cancer application is expected to register the highest CAGR over the forecast period, driven by the high specificity, small sizes, ease of modification, and high biocompatibility of peptides.
  • The total number of new cancer cases worldwide was estimated to be 19,292,789 in 2020, with 9,958,133 deaths due to cancers, according to the International Agency Research on Cancer- GLOBOCAN 2020 report.
  • The COVID-19 pandemic is expected to have disrupted the spectrum of cancer care, including delayed diagnoses, treatment, and halting clinical trials aimed at developing efficient therapeutics for cancer treatment.
  • North America is expected to dominate the overall market throughout the forecast period, driven by factors such as a rise in awareness levels relating to peptide therapeutics products, increasing necessity for diagnostics in cancer and other diseases, and the growing biotechnology industry.
  • The American Cancer Society estimates that in 2020, an estimated 1.8 million new cancer cases were diagnosed, and 606,520 cancer deaths were reported in the United States.
  • The COVID-19 pandemic caused major disruptions to clinical trial execution in the United States, with an estimated 80% of non-COVID-19 trials being stopped or interrupted as a result of the pandemic, according to a research article published in Applied Clinical Trials in October 2020.

Statistics:

  • The global peptide therapeutics market was valued at approximately USD 28,510.60 million in 2020.
  • The market is expected to reach USD 51,360.30 million by 2026, with a CAGR of 9.66%.
  • The total number of new cancer cases worldwide was estimated to be 19,292,789 in 2020.
  • The five-year prevalent cases of cancers were estimated to be 50,550,287 globally in 2020.
  • The number of new cancer cases is expected to reach 28,887,940 by 2040 worldwide.

Sources:

  • International Agency Research on Cancer- GLOBOCAN 2020 report
  • Research article published in Nature Cancer, 2020
  • American Cancer Society estimates for 2020
  • Research article published in Applied Clinical Trials in October 2020
  • ResearchAndMarkets.com report "Peptide Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)"

Read more